Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Care > Global Kidney Fibrosis Treatment Market Insights, Forecast to 2029

Global Kidney Fibrosis Treatment Market Insights, Forecast to 2029

Industry: Medical Care

Published: 2023-05-31

Pages: 91 Pages

Report ld: 1096239

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.

Market Analysis and Insights: Global Kidney Fibrosis Treatment Market

The global Kidney Fibrosis Treatment market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Increasing prevalence of chronic diseases such as kidney disorders is expected to trigger the growth of this market over the forecast period. Changing life style coupled with changing food habits is the prime reason for rising base of kidney disease patients and is expected to boost the market for kidney fibrosis treatments. Furthermore, factors such as increasing global geriatric population base, rising disposable income of the patients and growing awareness about renal fibrosis treatment are vital factor for growth of this market during the forecast period. Continuous innovation in technology has led to development of safe and effective therapies for the treatment of chronic kidney diseases is also pushing the growth of kidney fibrosis treatment market.
Report Includes
This report presents an overview of global market for Kidney Fibrosis Treatment market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Kidney Fibrosis Treatment, also provides the revenue of main regions and countries. of the upcoming market potential for Kidney Fibrosis Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Kidney Fibrosis Treatment revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Kidney Fibrosis Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Kidney Fibrosis Treatment revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Merck and Co(US), Pfizer Inc(US), F. Hoffman-La Roche(Switzerland), InterMune Inc(US), Galectin Therapeutics(US), La Jolla Pharmaceutical Company(US), ProMetic Life-Sciences Inc(Canada), BioLine Rx(Israel) and Genzyme Corporation(US), etc.

Report Metric
Details
Report Title
Global Kidney Fibrosis Treatment Market Insights, Forecast to 2029
Market Size Available for Years
2023-2029
Global Kidney Fibrosis Treatment Companies Covered
Merck and Co(US)
Pfizer Inc(US)
F. Hoffman-La Roche(Switzerland)
InterMune Inc(US)
Galectin Therapeutics(US)
La Jolla Pharmaceutical Company(US)
ProMetic Life-Sciences Inc(Canada)
BioLine Rx(Israel)
Genzyme Corporation(US)
Global Kidney Fibrosis Treatment Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Kidney Fibrosis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kidney Fibrosis Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Kidney Fibrosis Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Kidney Fibrosis Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
        1.2.2 Angiotensin Converting Enzyme (ACE) Inhibitors
        1.2.3 Pirfenidone
        1.2.4 Renin Inhibitors
        1.2.5 Angiotensin II Receptor Blockers (ARBs)
        1.2.6 Vasopeptidase Inhibitors
    1.3 Market by Application
        1.3.1 Global Kidney Fibrosis Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
        1.3.2 Chronic Kidney Diseases
        1.3.3 Kidney Cancer Treatment
        1.3.4 Others
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Global Growth Trends
    2.1 Global Kidney Fibrosis Treatment Market Perspective (2018-2029)
    2.2 Global Kidney Fibrosis Treatment Growth Trends by Region
        2.2.1 Kidney Fibrosis Treatment Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Kidney Fibrosis Treatment Historic Market Size by Region (2018-2023)
        2.2.3 Kidney Fibrosis Treatment Forecasted Market Size by Region (2024-2029)
    2.3 Kidney Fibrosis Treatment Market Dynamics
        2.3.1 Kidney Fibrosis Treatment Industry Trends
        2.3.2 Kidney Fibrosis Treatment Market Drivers
        2.3.3 Kidney Fibrosis Treatment Market Challenges
        2.3.4 Kidney Fibrosis Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Revenue Kidney Fibrosis Treatment by Players
        3.1.1 Global Kidney Fibrosis Treatment Revenue by Players (2018-2023)
        3.1.2 Global Kidney Fibrosis Treatment Revenue Market Share by Players (2018-2023)
    3.2 Global Kidney Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Global Key Players of Kidney Fibrosis Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
    3.4 Global Kidney Fibrosis Treatment Market Concentration Ratio
        3.4.1 Global Kidney Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Kidney Fibrosis Treatment Revenue in 2022
    3.5 Global Key Players of Kidney Fibrosis Treatment Head office and Area Served
    3.6 Global Key Players of Kidney Fibrosis Treatment, Product and Application
    3.7 Global Key Players of Kidney Fibrosis Treatment, Date of Enter into This Industry
    3.8 Mergers & Acquisitions, Expansion Plans

4 Kidney Fibrosis Treatment Breakdown Data by Type
    4.1 Global Kidney Fibrosis Treatment Historic Market Size by Type (2018-2023)
    4.2 Global Kidney Fibrosis Treatment Forecasted Market Size by Type (2024-2029)

5 Kidney Fibrosis Treatment Breakdown Data by Application
    5.1 Global Kidney Fibrosis Treatment Historic Market Size by Application (2018-2023)
    5.2 Global Kidney Fibrosis Treatment Forecasted Market Size by Application (2024-2029)

6 North America
    6.1 North America Kidney Fibrosis Treatment Market Size (2018-2029)
    6.2 North America Kidney Fibrosis Treatment Market Size by Type
        6.2.1 North America Kidney Fibrosis Treatment Market Size by Type (2018-2023)
        6.2.2 North America Kidney Fibrosis Treatment Market Size by Type (2024-2029)
        6.2.3 North America Kidney Fibrosis Treatment Market Share by Type (2018-2029)
    6.3 North America Kidney Fibrosis Treatment Market Size by Application
        6.3.1 North America Kidney Fibrosis Treatment Market Size by Application (2018-2023)
        6.3.2 North America Kidney Fibrosis Treatment Market Size by Application (2024-2029)
        6.3.3 North America Kidney Fibrosis Treatment Market Share by Application (2018-2029)
    6.4 North America Kidney Fibrosis Treatment Market Size by Country
        6.4.1 North America Kidney Fibrosis Treatment Market Size by Country: 2018 VS 2022 VS 2029
        6.4.2 North America Kidney Fibrosis Treatment Market Size by Country (2018-2023)
        6.4.3 North America Kidney Fibrosis Treatment Market Size by Country (2024-2029)
        6.4.4 U.S.
        6.4.5 Canada

7 Europe
    7.1 Europe Kidney Fibrosis Treatment Market Size (2018-2029)
    7.2 Europe Kidney Fibrosis Treatment Market Size by Type
        7.2.1 Europe Kidney Fibrosis Treatment Market Size by Type (2018-2023)
        7.2.2 Europe Kidney Fibrosis Treatment Market Size by Type (2024-2029)
        7.2.3 Europe Kidney Fibrosis Treatment Market Share by Type (2018-2029)
    7.3 Europe Kidney Fibrosis Treatment Market Size by Application
        7.3.1 Europe Kidney Fibrosis Treatment Market Size by Application (2018-2023)
        7.3.2 Europe Kidney Fibrosis Treatment Market Size by Application (2024-2029)
        7.3.3 Europe Kidney Fibrosis Treatment Market Share by Application (2018-2029)
    7.4 Europe Kidney Fibrosis Treatment Market Size by Country
        7.4.1 Europe Kidney Fibrosis Treatment Market Size by Country: 2018 VS 2022 VS 2029
        7.4.2 Europe Kidney Fibrosis Treatment Market Size by Country (2018-2023)
        7.4.3 Europe Kidney Fibrosis Treatment Market Size by Country (2024-2029)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries

8 China
    8.1 China Kidney Fibrosis Treatment Market Size (2018-2029)
    8.2 China Kidney Fibrosis Treatment Market Size by Type
        8.2.1 China Kidney Fibrosis Treatment Market Size by Type (2018-2023)
        8.2.2 China Kidney Fibrosis Treatment Market Size by Type (2024-2029)
        8.2.3 China Kidney Fibrosis Treatment Market Share by Type (2018-2029)
    8.3 China Kidney Fibrosis Treatment Market Size by Application
        8.3.1 China Kidney Fibrosis Treatment Market Size by Application (2018-2023)
        8.3.2 China Kidney Fibrosis Treatment Market Size by Application (2024-2029)
        8.3.3 China Kidney Fibrosis Treatment Market Share by Application (2018-2029)

9 Asia (excluding China)
    9.1 Asia Kidney Fibrosis Treatment Market Size (2018-2029)
    9.2 Asia Kidney Fibrosis Treatment Market Size by Type
        9.2.1 Asia Kidney Fibrosis Treatment Market Size by Type (2018-2023)
        9.2.2 Asia Kidney Fibrosis Treatment Market Size by Type (2024-2029)
        9.2.3 Asia Kidney Fibrosis Treatment Market Share by Type (2018-2029)
    9.3 Asia Kidney Fibrosis Treatment Market Size by Application
        9.3.1 Asia Kidney Fibrosis Treatment Market Size by Application (2018-2023)
        9.3.2 Asia Kidney Fibrosis Treatment Market Size by Application (2024-2029)
        9.3.3 Asia Kidney Fibrosis Treatment Market Share by Application (2018-2029)
    9.4 Asia Kidney Fibrosis Treatment Market Size by Region
        9.4.1 Asia Kidney Fibrosis Treatment Market Size by Region: 2018 VS 2022 VS 2029
        9.4.2 Asia Kidney Fibrosis Treatment Market Size by Region (2018-2023)
        9.4.3 Asia Kidney Fibrosis Treatment Market Size by Region (2024-2029)
        9.4.4 Japan
        9.4.5 South Korea
        9.4.6 China Taiwan
        9.4.7 Southeast Asia
        9.4.8 India
        9.4.9 Australia

10 Middle East, Africa, and Latin America
    10.1 Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Size (2018-2029)
    10.2 Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Size by Type
        10.2.1 Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Size by Type (2018-2023)
        10.2.2 Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Size by Type (2024-2029)
        10.2.3 Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Share by Type (2018-2029)
    10.3 Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Size by Application
        10.3.1 Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Size by Application (2018-2023)
        10.3.2 Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Size by Application (2024-2029)
        10.3.3 Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Share by Application (2018-2029)
    10.4 Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Size by Country
        10.4.1 Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Size by Country: 2018 VS 2022 VS 2029
        10.4.2 Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Size by Country (2018-2023)
        10.4.3 Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Size by Country (2024-2029)
        10.4.4 Brazil
        10.4.5 Mexico
        10.4.6 Turkey
        10.4.7 Saudi Arabia
        10.4.8 Israel
        10.4.9 GCC Countries

11 Key Players Profiles
    11.1 Merck and Co(US)
        11.1.1 Merck and Co(US) Company Details
        11.1.2 Merck and Co(US) Business Overview
        11.1.3 Merck and Co(US) Kidney Fibrosis Treatment Introduction
        11.1.4 Merck and Co(US) Revenue in Kidney Fibrosis Treatment Business (2018-2023)
        11.1.5 Merck and Co(US) Recent Developments
    11.2 Pfizer Inc(US)
        11.2.1 Pfizer Inc(US) Company Details
        11.2.2 Pfizer Inc(US) Business Overview
        11.2.3 Pfizer Inc(US) Kidney Fibrosis Treatment Introduction
        11.2.4 Pfizer Inc(US) Revenue in Kidney Fibrosis Treatment Business (2018-2023)
        11.2.5 Pfizer Inc(US) Recent Developments
    11.3 F. Hoffman-La Roche(Switzerland)
        11.3.1 F. Hoffman-La Roche(Switzerland) Company Details
        11.3.2 F. Hoffman-La Roche(Switzerland) Business Overview
        11.3.3 F. Hoffman-La Roche(Switzerland) Kidney Fibrosis Treatment Introduction
        11.3.4 F. Hoffman-La Roche(Switzerland) Revenue in Kidney Fibrosis Treatment Business (2018-2023)
        11.3.5 F. Hoffman-La Roche(Switzerland) Recent Developments
    11.4 InterMune Inc(US)
        11.4.1 InterMune Inc(US) Company Details
        11.4.2 InterMune Inc(US) Business Overview
        11.4.3 InterMune Inc(US) Kidney Fibrosis Treatment Introduction
        11.4.4 InterMune Inc(US) Revenue in Kidney Fibrosis Treatment Business (2018-2023)
        11.4.5 InterMune Inc(US) Recent Developments
    11.5 Galectin Therapeutics(US)
        11.5.1 Galectin Therapeutics(US) Company Details
        11.5.2 Galectin Therapeutics(US) Business Overview
        11.5.3 Galectin Therapeutics(US) Kidney Fibrosis Treatment Introduction
        11.5.4 Galectin Therapeutics(US) Revenue in Kidney Fibrosis Treatment Business (2018-2023)
        11.5.5 Galectin Therapeutics(US) Recent Developments
    11.6 La Jolla Pharmaceutical Company(US)
        11.6.1 La Jolla Pharmaceutical Company(US) Company Details
        11.6.2 La Jolla Pharmaceutical Company(US) Business Overview
        11.6.3 La Jolla Pharmaceutical Company(US) Kidney Fibrosis Treatment Introduction
        11.6.4 La Jolla Pharmaceutical Company(US) Revenue in Kidney Fibrosis Treatment Business (2018-2023)
        11.6.5 La Jolla Pharmaceutical Company(US) Recent Developments
    11.7 ProMetic Life-Sciences Inc(Canada)
        11.7.1 ProMetic Life-Sciences Inc(Canada) Company Details
        11.7.2 ProMetic Life-Sciences Inc(Canada) Business Overview
        11.7.3 ProMetic Life-Sciences Inc(Canada) Kidney Fibrosis Treatment Introduction
        11.7.4 ProMetic Life-Sciences Inc(Canada) Revenue in Kidney Fibrosis Treatment Business (2018-2023)
        11.7.5 ProMetic Life-Sciences Inc(Canada) Recent Developments
    11.8 BioLine Rx(Israel)
        11.8.1 BioLine Rx(Israel) Company Details
        11.8.2 BioLine Rx(Israel) Business Overview
        11.8.3 BioLine Rx(Israel) Kidney Fibrosis Treatment Introduction
        11.8.4 BioLine Rx(Israel) Revenue in Kidney Fibrosis Treatment Business (2018-2023)
        11.8.5 BioLine Rx(Israel) Recent Developments
    11.9 Genzyme Corporation(US)
        11.9.1 Genzyme Corporation(US) Company Details
        11.9.2 Genzyme Corporation(US) Business Overview
        11.9.3 Genzyme Corporation(US) Kidney Fibrosis Treatment Introduction
        11.9.4 Genzyme Corporation(US) Revenue in Kidney Fibrosis Treatment Business (2018-2023)
        11.9.5 Genzyme Corporation(US) Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Table of Figures

List of Tables
    Table 1. Global Kidney Fibrosis Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
    Table 2. Key Players of Angiotensin Converting Enzyme (ACE) Inhibitors
    Table 3. Key Players of Pirfenidone
    Table 4. Key Players of Renin Inhibitors
    Table 5. Key Players of Angiotensin II Receptor Blockers (ARBs)
    Table 6. Key Players of Vasopeptidase Inhibitors
    Table 7. Global Kidney Fibrosis Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
    Table 8. Global Kidney Fibrosis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Kidney Fibrosis Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 10. Global Kidney Fibrosis Treatment Market Share by Region (2018-2023)
    Table 11. Global Kidney Fibrosis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 12. Global Kidney Fibrosis Treatment Market Share by Region (2024-2029)
    Table 13. Kidney Fibrosis Treatment Market Trends
    Table 14. Kidney Fibrosis Treatment Market Drivers
    Table 15. Kidney Fibrosis Treatment Market Challenges
    Table 16. Kidney Fibrosis Treatment Market Restraints
    Table 17. Global Kidney Fibrosis Treatment Revenue by Players (2018-2023) & (US$ Million)
    Table 18. Global Kidney Fibrosis Treatment Revenue Share by Players (2018-2023)
    Table 19. Global Top Kidney Fibrosis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Fibrosis Treatment as of 2022)
    Table 20. Global Kidney Fibrosis Treatment Industry Ranking 2021 VS 2022 VS 2023
    Table 21. Global 5 Largest Players Market Share by Kidney Fibrosis Treatment Revenue (CR5 and HHI) & (2018-2023)
    Table 22. Global Key Players of Kidney Fibrosis Treatment, Headquarters and Area Served
    Table 23. Global Key Players of Kidney Fibrosis Treatment, Product and Application
    Table 24. Global Key Players of Kidney Fibrosis Treatment, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Kidney Fibrosis Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 27. Global Kidney Fibrosis Treatment Revenue Market Share by Type (2018-2023)
    Table 28. Global Kidney Fibrosis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 29. Global Kidney Fibrosis Treatment Revenue Market Share by Type (2024-2029)
    Table 30. Global Kidney Fibrosis Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 31. Global Kidney Fibrosis Treatment Revenue Share by Application (2018-2023)
    Table 32. Global Kidney Fibrosis Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 33. Global Kidney Fibrosis Treatment Revenue Share by Application (2024-2029)
    Table 34. North America Kidney Fibrosis Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 35. North America Kidney Fibrosis Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 36. North America Kidney Fibrosis Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 37. North America Kidney Fibrosis Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 38. North America Kidney Fibrosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 39. North America Kidney Fibrosis Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 40. North America Kidney Fibrosis Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 41. Europe Kidney Fibrosis Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 42. Europe Kidney Fibrosis Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 43. Europe Kidney Fibrosis Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 44. Europe Kidney Fibrosis Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 45. Europe Kidney Fibrosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 46. Europe Kidney Fibrosis Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 47. Europe Kidney Fibrosis Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 48. China Kidney Fibrosis Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 49. China Kidney Fibrosis Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 50. China Kidney Fibrosis Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 51. China Kidney Fibrosis Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 52. Asia Kidney Fibrosis Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 53. Asia Kidney Fibrosis Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 54. Asia Kidney Fibrosis Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 55. Asia Kidney Fibrosis Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 56. Asia Kidney Fibrosis Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 57. Asia Kidney Fibrosis Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 58. Asia Kidney Fibrosis Treatment Market Size by Region (2024-2029) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Kidney Fibrosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 64. Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 66. Merck and Co(US) Company Details
    Table 67. Merck and Co(US) Business Overview
    Table 68. Merck and Co(US) Kidney Fibrosis Treatment Product
    Table 69. Merck and Co(US) Revenue in Kidney Fibrosis Treatment Business (2018-2023) & (US$ Million)
    Table 70. Merck and Co(US) Recent Developments
    Table 71. Pfizer Inc(US) Company Details
    Table 72. Pfizer Inc(US) Business Overview
    Table 73. Pfizer Inc(US) Kidney Fibrosis Treatment Product
    Table 74. Pfizer Inc(US) Revenue in Kidney Fibrosis Treatment Business (2018-2023) & (US$ Million)
    Table 75. Pfizer Inc(US) Recent Developments
    Table 76. F. Hoffman-La Roche(Switzerland) Company Details
    Table 77. F. Hoffman-La Roche(Switzerland) Business Overview
    Table 78. F. Hoffman-La Roche(Switzerland) Kidney Fibrosis Treatment Product
    Table 79. F. Hoffman-La Roche(Switzerland) Revenue in Kidney Fibrosis Treatment Business (2018-2023) & (US$ Million)
    Table 80. F. Hoffman-La Roche(Switzerland) Recent Developments
    Table 81. InterMune Inc(US) Company Details
    Table 82. InterMune Inc(US) Business Overview
    Table 83. InterMune Inc(US) Kidney Fibrosis Treatment Product
    Table 84. InterMune Inc(US) Revenue in Kidney Fibrosis Treatment Business (2018-2023) & (US$ Million)
    Table 85. InterMune Inc(US) Recent Developments
    Table 86. Galectin Therapeutics(US) Company Details
    Table 87. Galectin Therapeutics(US) Business Overview
    Table 88. Galectin Therapeutics(US) Kidney Fibrosis Treatment Product
    Table 89. Galectin Therapeutics(US) Revenue in Kidney Fibrosis Treatment Business (2018-2023) & (US$ Million)
    Table 90. Galectin Therapeutics(US) Recent Developments
    Table 91. La Jolla Pharmaceutical Company(US) Company Details
    Table 92. La Jolla Pharmaceutical Company(US) Business Overview
    Table 93. La Jolla Pharmaceutical Company(US) Kidney Fibrosis Treatment Product
    Table 94. La Jolla Pharmaceutical Company(US) Revenue in Kidney Fibrosis Treatment Business (2018-2023) & (US$ Million)
    Table 95. La Jolla Pharmaceutical Company(US) Recent Developments
    Table 96. ProMetic Life-Sciences Inc(Canada) Company Details
    Table 97. ProMetic Life-Sciences Inc(Canada) Business Overview
    Table 98. ProMetic Life-Sciences Inc(Canada) Kidney Fibrosis Treatment Product
    Table 99. ProMetic Life-Sciences Inc(Canada) Revenue in Kidney Fibrosis Treatment Business (2018-2023) & (US$ Million)
    Table 100. ProMetic Life-Sciences Inc(Canada) Recent Developments
    Table 101. BioLine Rx(Israel) Company Details
    Table 102. BioLine Rx(Israel) Business Overview
    Table 103. BioLine Rx(Israel) Kidney Fibrosis Treatment Product
    Table 104. BioLine Rx(Israel) Revenue in Kidney Fibrosis Treatment Business (2018-2023) & (US$ Million)
    Table 105. BioLine Rx(Israel) Recent Developments
    Table 106. Genzyme Corporation(US) Company Details
    Table 107. Genzyme Corporation(US) Business Overview
    Table 108. Genzyme Corporation(US) Kidney Fibrosis Treatment Product
    Table 109. Genzyme Corporation(US) Revenue in Kidney Fibrosis Treatment Business (2018-2023) & (US$ Million)
    Table 110. Genzyme Corporation(US) Recent Developments
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Kidney Fibrosis Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 2. Global Kidney Fibrosis Treatment Market Share by Type: 2022 VS 2029
    Figure 3. Angiotensin Converting Enzyme (ACE) Inhibitors Features
    Figure 4. Pirfenidone Features
    Figure 5. Renin Inhibitors Features
    Figure 6. Angiotensin II Receptor Blockers (ARBs) Features
    Figure 7. Vasopeptidase Inhibitors Features
    Figure 8. Global Kidney Fibrosis Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 9. Global Kidney Fibrosis Treatment Market Share by Application: 2022 VS 2029
    Figure 10. Chronic Kidney Diseases Case Studies
    Figure 11. Kidney Cancer Treatment Case Studies
    Figure 12. Others Case Studies
    Figure 13. Kidney Fibrosis Treatment Report Years Considered
    Figure 14. Global Kidney Fibrosis Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 15. Global Kidney Fibrosis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 16. Global Kidney Fibrosis Treatment Market Share by Region: 2022 VS 2029
    Figure 17. Global Kidney Fibrosis Treatment Market Share by Players in 2022
    Figure 18. Global Top Kidney Fibrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Fibrosis Treatment as of 2022)
    Figure 19. The Top 10 and 5 Players Market Share by Kidney Fibrosis Treatment Revenue in 2022
    Figure 20. North America Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. North America Kidney Fibrosis Treatment Market Share by Type (2018-2029)
    Figure 22. North America Kidney Fibrosis Treatment Market Share by Application (2018-2029)
    Figure 23. North America Kidney Fibrosis Treatment Market Share by Country (2018-2029)
    Figure 24. United States Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Canada Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Europe Kidney Fibrosis Treatment Market Size YoY (2018-2029) & (US$ Million)
    Figure 27. Europe Kidney Fibrosis Treatment Market Share by Type (2018-2029)
    Figure 28. Europe Kidney Fibrosis Treatment Market Share by Application (2018-2029)
    Figure 29. Europe Kidney Fibrosis Treatment Market Share by Country (2018-2029)
    Figure 30. Germany Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. France Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. U.K. Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Italy Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Russia Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Nordic Countries Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. China Kidney Fibrosis Treatment Market Size YoY (2018-2029) & (US$ Million)
    Figure 37. China Kidney Fibrosis Treatment Market Share by Type (2018-2029)
    Figure 38. China Kidney Fibrosis Treatment Market Share by Application (2018-2029)
    Figure 39. Asia Kidney Fibrosis Treatment Market Size YoY (2018-2029) & (US$ Million)
    Figure 40. Asia Kidney Fibrosis Treatment Market Share by Type (2018-2029)
    Figure 41. Asia Kidney Fibrosis Treatment Market Share by Application (2018-2029)
    Figure 42. Asia Kidney Fibrosis Treatment Market Share by Region (2018-2029)
    Figure 43. Japan Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. South Korea Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. China Taiwan Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Southeast Asia Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. India Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Australia Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Size YoY (2018-2029) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Share by Type (2018-2029)
    Figure 51. Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Share by Application (2018-2029)
    Figure 52. Middle East, Africa, and Latin America Kidney Fibrosis Treatment Market Share by Country (2018-2029)
    Figure 53. Brazil Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 54. Mexico Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 55. Turkey Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 56. Saudi Arabia Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 57. Israel Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 58. GCC Countries Kidney Fibrosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 59. Merck and Co(US) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2018-2023)
    Figure 60. Pfizer Inc(US) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2018-2023)
    Figure 61. F. Hoffman-La Roche(Switzerland) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2018-2023)
    Figure 62. InterMune Inc(US) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2018-2023)
    Figure 63. Galectin Therapeutics(US) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2018-2023)
    Figure 64. La Jolla Pharmaceutical Company(US) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2018-2023)
    Figure 65. ProMetic Life-Sciences Inc(Canada) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2018-2023)
    Figure 66. BioLine Rx(Israel) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2018-2023)
    Figure 67. Genzyme Corporation(US) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2018-2023)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed

Description

Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.

Market Analysis and Insights: Global Kidney Fibrosis Treatment Market

The global Kidney Fibrosis Treatment market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Related Reports

Global Kidney Fibrosis Treatment Market Research Report 2023
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2023-06-11
Pages: 85
USD 2900.00
(Single User License)
Global Kidney Fibrosis Treatment Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2023-05-30
Pages: 102
USD 5600.00
(Single User License)
Global Kidney Fibrosis Treatment Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2023-05-30
Pages: 88
USD 3350.00
(Single User License)
Global Kidney Fibrosis Treatment Market Research Report 2024
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2024-01-04
Pages: 78
USD 2900.00
(Single User License)
Kidney Fibrosis Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2024-01-24
Pages: 92
USD 3950.00
(Single User License)
Global Kidney Fibrosis Treatment Market Insights, Forecast to 2030
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.
Published: 2024-04-28
Pages: 88
USD 4900.00
(Single User License)
Global Kidney Fibrosis Treatment Market Research Report 2025
The global market for Kidney Fibrosis Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-27
Pages: 71
USD 2900.00
(Single User License)
Kidney Fibrosis Treatment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Kidney Fibrosis Treatment was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 89
USD 3950.00
(Single User License)